Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127818) titled 'Construction of an evaluation system for the cardiac safety of anti - tumor drugs based on multi - modal data models' on July 8.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Harbin Medical University Cancer Hospital

Condition: Malignant solid tumors (lung cancer, breast cancer, gastrointestinal cancer, ovarian cancer, etc.), antineoplastic drug-related cardiotoxicity (myocardial injury, cardiac dysfunction, arrhythmia, heart failure, etc.)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-07-08

Target Sample Size: Antineoplastic drug treatment gr...